The relevance of tumor mutation profiling in interpretation of NGS data from cell-free DNA in non-small cell lung cancer patients
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 112, 104347
Abstract
No abstract availableKeywords
Funding Information
- Helse Midt-Norge
This publication has 18 references indexed in Scilit:
- Comparison of plasma to tissue DNA mutations in surgical patients with non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2017
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolutionNature, 2017
- CAPP-Seq Circulating Tumor DNA Analysis for Early Detection of Tumor Progression After Definitive Radiation Therapy for Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
- Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancerAnnals of Oncology, 2016
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human MalignanciesScience Translational Medicine, 2014
- Histologic coagulative tumour necrosis as a prognostic indicator of aggressiveness in renal, lung, thyroid and colorectal carcinomas: A brief reviewOncology Letters, 2011
- High Fragmentation Characterizes Tumour-Derived Circulating DNAPLOS ONE, 2011
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithmNature Protocols, 2009
- About the possible origin and mechanism of circulating DNAClinica Chimica Acta, 2001